Earnings calendar

Moderna, Inc. (MRNA) earnings: date, estimates, results and stock reactions

Next earnings: Q4 FY2026 on 2027-02-12 (expected, time not announced). EPS estimate -2.08, revenue estimate 529.7M.

Over the last 12 reports the stock moved 9.5% on average (either way), rising 7 times and falling 5. EPS beat estimates 12 of 12 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-060.38-1.10+134.5%1.31B890.3M+11.4%
Q2 FY20262026-07-31-1.97-2.03+3.0%145.0M102.9M-4.8%
Q1 FY20262026-05-01-3.40-4.45+23.6%389.0M236.4M+3.0%
Q4 FY20252026-02-13-2.11-2.54+16.9%678.0M635.2M+9.5%
Q3 FY20252025-11-06-0.51-1.87+72.7%1.02B920.9M+4.2%
Q2 FY20252025-08-01-2.13-2.99+28.8%142.0M893.3M-6.5%
Q1 FY20252025-05-01-2.52-2.92+13.7%107.0M116.7M-3.3%
Q4 FY20242025-02-14-2.50-2.68+6.7%956.0M942.8M+12.0%

MRNA stock report · Earnings calendar